Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 38 (1) , 67-72
- https://doi.org/10.1038/ki.1990.168
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- EFFECTS OF UK 69 578: A NOVEL ATRIOPEPTIDASE INHIBITORPublished by Elsevier ,1989
- Degradation of atrial natriuretic peptides by an enzyme in rat kidney resembling neutral endopeptidase 24.11Biochemical Pharmacology, 1988
- Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor.Circulation Research, 1988
- Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidneyPeptides, 1988
- Intrarenal localization of degradation of atrial natriuretic peptide in isolated glomeruli and cortical nephron segmentsLife Sciences, 1988
- Atrial peptide inactivation by rabbit‐kidney brush‐border membranesEuropean Journal of Biochemistry, 1987
- Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog.Circulation Research, 1987
- The hydrolysis of α-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11Biochemical Journal, 1987
- An immunoradiometric assay for endopeptidase-24.11 shows it to be a widely distributed enzyme in pig tissuesBiochemical Journal, 1985
- Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogsThe American Journal of Medicine, 1984